Table 2.
Group differences in connectivity profiles between patients and controls.
| Measure | Mean HC (SD) | Mean PT (SD) | F-statistic (df) | ƞ2 | p |
|---|---|---|---|---|---|
| FWHM | 0.539 (0.149) | 0.725 (0.191) | 15.752 (1,89) | 0.152 | < 0.001** |
| Peak position | 0.303 (0.180) | 0.527 (0.227) | 15.306 (1,89) | 0.151 | 0.001** |
| Peak height | 1.952 (0.370) | 1.528 (0.406) | 17.607 (1,89) | 0.169 | < 0.001** |
| Hub conn | 1.180 (0.208) | 1.040 (0.126) | 11.270 (1,89) | 0.114 | 0.001** |
| Hub-non-hub conn | 0.931 (0.071) | 0.974 (0.040) | 12.351 (1,89) | 0.129 | 0.001** |
| Non-hub conn | 1.028 (0.439) | 1.013 (0.034) | 2.833 (1,89) | 0.033 | 0.096 |
ANOVAs were corrected for sex, age, and motion, which were not significant in any model. As a measure of effect size, eta squared is reported. **Denotes p < 0.01 (after correction for multiple comparisons). Values in bold represent identical significance when using the 264 region atlas instead of the AAL atlas. HC = healthy controls (n = 19); SD = standard deviation; PT = glioma patients (n = 71), FWHM = full-width half maximum, conn = connectivity.